NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for September 20091. Trading volumes in September 2009 were mostly lower compared to September 2008 levels, during which crisis-level volatility drove near-record trading volumes. While trading volumes declined year-over-year, volumes in September increased from August 2009 levels with U.S. and European cash products increasing 2.9% and 13.2%, respectively, and U.S. and European derivatives products increasing 30.0% and 24.4%, respectively.

Highlights

• NYSE, NYSE Arca and NYSE Amex (“NYSE Group”) U.S. cash products handled ADV of 3.0 billion shares in September 2009 decreased 30.8% compared to September 2008, but increased 2.9% compared to August 2009. NYSE Group matched share of all U.S. equity trading volume in September 2009 was 28.0%, up from 27.4% in August 2009, and compared to matched market share of 22.6% for our next largest competitor. NYSE Group’s Tape A matched market share in September 2009 was 36.1%, up from 33.8% in August 2009.
• NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Year-to-date, total Tape A and Tape B consolidated ADV of 8.0 billion shares increased a combined 32.9%, compared to the prior year period, while Tape C consolidated ADV of 2.3 billion shares has increased only 1.4% during the same period.
• NYSE Euronext European cash products ADV of 1.5 million transactions in September 2009 decreased 20.2% compared to September 2008, but increased 13.2% from August 2009.
• NYSE Euronext European derivatives products ADV in September 2009 of 4.4 million contracts decreased 9.3% compared to September 2008, but increased 24.4% from August 2009. Total interest rate products ADV in September 2009 of 2.3 million contracts increased 0.4% compared to September 2008 and total equity products ADV of 2.0 million contracts decreased 18.4% compared to September 2008.
• NYSE Euronext U.S. equity options ADV of 3.0 million contracts in September 2009 increased 49.4% compared to September 2008 levels, and increased 30.0% from August 2009. NYSE Euronext’s U.S. options exchanges accounted for 21.4% of the total consolidated equity options trading in September 2009, up from 12.3% in September 2008, and up from 18.2% in August 2009. The increase in ADV and market share year-over-year was driven mostly by the addition of the former Amex options business. The increase in ADV and market share compared to August was driven in part by increased trading related to the anticipated sale of an equity stake in NYSE Amex Options and NYSE Amex Options pricing changes implemented July 1, 2009.
• NYSE Liffe U.S. futures and futures options ADV in September 2009 of approximately 21,000 contracts increased from approximately 12,000 contracts in August 2009 with the launch of equity index futures trading in September based on the MSCI U.S., EM and EAFE indexes.

Cash Trading

U.S. Cash

• NYSE Group U.S. cash products handled ADV in September 2009 decreased 30.8% to 3.0 billion shares, compared to September 2008, but increased 2.9% from August 2009. In the third quarter of 2009, ADV of 2.9 billion was 19.2% below the third quarter of 2008. Year-to-date, NYSE Group handled ADV of 3.5 billion shares was 5.2% above the same period last year.
• NYSE Group matched share of all U.S. equity volume in September 2009 was 28.0%, compared to matched market share of 22.6% for our next largest competitor.
• Consolidated Tape A and Tape B trading volume in September accounted for approximately 75% of all Consolidated Tape trading in the U.S. market which includes trade reporting facility (“TRF”) volumes.

NYSE-listed (Tape A)

• Total Tape A consolidated ADV in September 2009 decreased 16.5% to 5.7 billion shares compared to 6.8 billion shares in September 2008 and decreased 3.5% compared to August 2009. In the third quarter of 2009, total Tape A consolidated ADV of 5.5 billion shares was 1.5% below the third quarter of 2008. Year-to-date, total Tape A consolidated ADV of 6.0 billion shares was 25.1% above the prior year period.
• Tape A matched ADV of NYSE Group in September 2009 decreased 28.5% to 2.1 billion shares compared to September 2008, but increased 3.3% compared to August 2009. In the third quarter 2009, Tape A matched ADV of 2.0 billion shares was 17.9% below the third quarter of 2008. Year-to-date, NYSE Group matched ADV in Tape A increased 4.0% compared to the prior year period.
• NYSE Group’s Tape A matched market share in September 2009 was 36.1%, up from 33.8% in August 2009, and compared to matched market share of 17.7% for our next largest competitor. TRF market share across Tape A was 34.8%, down from 37.6% in August 2009, but up from 25.0% in December 2008.
• Designated Market Maker (“DMM”) participation in September 2009 was 9.1%, compared to 8.8% in August 2009. Supplemental Liquidity Provider (“SLP”) participation in September 2009 was 9.5%, compared to 7.6% in August 2009. A total of 6 SLPs are now on the platform. DMM and SLP participation pertain only to trading on NYSE.

NYSE Arca and NYSE Amex-listed (Tape B)

• Total Tape B consolidated ADV in September 2009 decreased 24.4% to 1.5 billion shares compared to September 2008, but increased 2.9% compared to August 2009. In the third quarter of 2009, total Tape B consolidated ADV of 1.5 billion shares was 4.8% below the third quarter of 2008. Year-to-date, total Tape B consolidated ADV of 2.0 billion shares was 62.4% above the prior year period.
• NYSE Group’s matched ADV of Tape B in September 2009 decreased 40.7% to 348 million shares compared to September 2008 and was flat compared to August 2009. In the third quarter of 2009, Tape B matched ADV of 352 million shares decreased 20.9% compared to the third quarter of 2008. Year-to-date, NYSE Group Tape B matched ADV was 37.8% above the prior year period.
• Tape B matched market share of NYSE Group in September 2009 was 22.6%, down from 23.3% in August 2009, compared to matched market share of 25.1% for our next largest competitor. TRF market share across Tape B in September 2009 was 34.4% compared to 21.5% in December 2008.

Nasdaq-listed (Tape C)

• Total Tape C consolidated ADV in September 2009 decreased 4.8% to 2.4 billion shares, compared to 2.5 billion shares in September 2008. Total Tape C consolidated volumes represented approximately 25% of all consolidated tape trading in the U.S. in September 2009. In the third quarter of 2009, total Tape C consolidated ADV of 2.3 billion shares declined slightly compared to the third quarter of 2008. Year-to-date, total Tape C consolidated ADV was 1.4% above the prior year period.
• NYSE Group’s matched ADV of Tape C decreased 33.4% to 295 million shares in September 2009 compared to 443 million shares in September 2008, but increased 8.9% compared to August 2009. In the third quarter of 2009, Tape C matched ADV of 284 million shares decreased 26.4% compared to the third quarter of 2008. Year-to-date, NYSE Group’s Tape C matched ADV decreased 16.2% to 318 million shares.
• NYSE Group’s Tape C matched market share in September 2009 decreased to 12.2% from 12.6% in August 2009, compared to matched market share of 32.4% for our nearest competitor. TRF market share across Tape C in August 2009 was 40.9% compared to 29.9% in December 2008.

Exchange Traded Products

• NYSE Group matched exchange-traded products ADV (included in volumes from Tape B and Tape C noted above) of 317 millions shares in September 2009 decreased 49.1% compared to September 2008. In the third quarter of 2009, matched exchange-traded products ADV of 335 million shares was 29.3% below the third quarter of 2008. Year-to-date, matched exchange-traded products ADV was 27.2% above the prior year period.

European Cash

• NYSE Euronext European cash products ADV of 1.5 million transactions in September 2009 decreased 20.2%, compared to September 2008, but increased 13.2% compared to August 2009 and represented the second consecutive monthly increase in ADV. In the third quarter of 2009, European cash products ADV of 1.3 million transactions decreased 15.0% compared to the third quarter of 2008. Year-to-date, European cash products ADV of 1.4 million transactions was 9.5% below the same period last year.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in September 2009 was 4.4 million futures and options contracts, a decrease of 9.3% from September 2008, but an increase of 24.4% from the 3.5 million contracts recorded in August 2009. The 4.4 million in futures and options contracts ADV in September 2009 consisted of 3.5 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.8 million, or 19.3%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
• In the third quarter of 2009, European derivatives products ADV was 3.8 million contracts, 1.4% above the third quarter of 2008. The 3.8 million in futures and options contracts ADV in the third quarter of 2009 consisted of 2.9 million contracts executed through LIFFE CONNECT and 0.9 million contracts, or 22.4%, executed through Bclear. Year-to-date European derivatives products ADV of 4.1 million contracts was 2.1% below prior year levels.
• Total interest rate products ADV of 2.3 million contracts in September 2009 increased 0.4% and 22.2% from September 2008 and August 2009, respectively. In the third quarter of 2009, interest rate products ADV of 1.9 million contracts was down 0.7% from the third quarter of 2008. Year-to-date, total interest rate products ADV decreased 12.8% compared to the prior year period.
• Total equity products (including Bclear) ADV of 2.0 million contracts in September 2009 decreased 18.4% compared to September 2008, but increased 27.1% compared to August 2009. In the third quarter of 2009, total equity products ADV of 1.9 million contracts, including 1.0 million contracts executed through LIFFE CONNECT, was 3.8% above the 1.8 million contracts executed in the third quarter of 2008 which included 1.1 million contracts executed through LIFFE CONNECT. Year-to-date total equity products ADV increased 11.3% from the prior year period driven primarily by a 41.6% increase in volume executed through Bclear.

U.S. Derivatives

• NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.0 million contracts in September 2009 increased 49.4% compared to September 2008 and increased 30.0% compared to August 2009. In the third quarter of 2009, NYSE group U.S. equity options ADV of 2.6 million contracts increased 46.3% compared to the third quarter of 2008. Year-to-date, NYSE Group U.S. equity options volume of 2.5 million contracts was 43.1% above the prior year period.
• Total U.S. consolidated options ADV decreased 13.9% to 14.0 million contracts in September 2009, but increased 10.1% compared to August 2009. In the third quarter of 2009, U.S. consolidated options ADV of 13.2 million contracts decreased 8.1% compared to the third quarter of 2008. Year-to-date, U.S. consolidated options ADV of 13.5 million contracts was 1.4% above the prior year period.
• NYSE Euronext’s U.S. options exchanges accounted for 21.4% of the total consolidated equity options trading in September 2009, up from 12.3% in September 2008, and up from 18.2% in August 2009. The increase in ADV and market share year-over-year was driven mostly by the addition of the former Amex options business. The increase in ADV and market share compared to August was driven in part by increased trading related to the anticipated sale of an equity stake in NYSE Amex Options and NYSE Amex Options pricing changes implemented July 1, 2009.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in September 2009 of approximately 21,000 contracts increased from approximately 12,000 contracts in August 2009 with the launch of equity index futures trading in September based on the MSCI U.S., EM and EAFE indexes. There are no fees for MSCI equity index futures trading through December 2009.

Other Metrics

• The average EUR/USD exchange rate for the third quarter of 2009 of $1.43 represented an increase of 4.9% from the second quarter of 2009, but a decrease of 4.9% compared to the third quarter of 2008. Year-to-date, the average EUR/USD exchange rate is running 10.2% below the same period last year.
• The average GBP/USD exchange rate for the third quarter of 2009 of $1.64 represented an increase of 5.8% from the second quarter of 2009, but a decrease of 13.3% compared to the third quarter of 2008. Year-to-date, the average GBP/USD exchange rate is running 20.8% below the same period last year.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, NYSE Euronext, NYSE Amex and NYSE Alternext as well as NYSE Arca – represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2008 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. Prior year period does not include the former Amex equities and options businesses.

NYSE Euronext

Monthly Volume Summary - Cash Products

                  Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited) Sep-09 Sep-08 % Chg Sep-09 Sep-08 % Chg YTD 2009

% Chg vs. YTD 2008

YTD 2009

% Chg vs. YTD 2008

 

Number of Trading Days - European Markets 22 22 22 22 191 191 Number of Trading Days - U.S. Markets 21 21 21 21 188 188   European Cash Products (trades in thousands) 1,475 1,848 -20.2 % 32,443 40,661 -20.2 % 1,381 -9.5 % 263,858 -10.0 %   Equities 1,420 1,787 -20.5 % 31,241 39,316 -20.5 % 1,323 -10.3 % 252,636 -10.8 % Exchange-Traded Funds 14 11 32.9 % 309 232 32.9 % 14 81.0 % 2,694 80.1 % Structured Products 35 46 -24.0 % 762 1,003 -24.0 % 39 0.1 % 7,459 -0.4 % Bonds 6 5 20.0 % 131 110 20.0 % 6 7.5 % 1,069 6.9 %   U.S. Cash Products (shares in millions) 2 3,021 4,366 -30.8 % 63,446 91,684 -30.8 % 3,523 5.2 % 662,283 4.7 %   NYSE Listed (Tape A) Issues 1   NYSE Group Handled Volume 2 2,249 3,179 -29.2 % 47,238 66,768 -29.2 % 2,569 3.4 % 482,915 2.9 % NYSE Group Matched Volume 3 2,054 2,872 -28.5 % 43,132 60,308 -28.5 % 2,330 4.0 % 438,119 3.5 % Total NYSE Listed Consolidated Volume 5,686 6,812 -16.5 % 119,414 143,061 -16.5 % 5,996 25.1 % 1,127,225 24.5 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 39.6 % 46.7 % -7.1 % 39.6 % 46.7 % -7.1 % 42.8 % -9.0 % 42.8 % -9.0 % Matched Volume 3 36.1 % 42.2 % -6.1 % 36.1 % 42.2 % -6.1 % 38.9 % -7.9 % 38.9 % -7.9 %   NYSE Arca & Amex (Tape B) Listed Issues   NYSE Group Handled Volume 2 402 669 -39.9 % 8,447 14,056 -39.9 % 564 37.0 % 106,095 36.3 % NYSE Group Matched Volume 3 348 586 -40.7 % 7,308 12,316 -40.7 % 494 37.8 % 92,784 37.1 % Total NYSE Arca & Amex Listed Consolidated Volume 1,541 2,037 -24.4 % 32,357 42,783 -24.4 % 2,043 62.4 % 384,083 61.6 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 26.1 % 32.9 % -6.8 % 26.1 % 32.9 % -6.8 % 27.6 % -5.1 % 27.6 % -5.1 % Matched Volume 3 22.6 % 28.8 % -6.2 % 22.6 % 28.8 % -6.2 % 24.2 % -4.3 % 24.2 % -4.3 %   Nasdaq Listed (Tape C) Issues   NYSE Group Handled Volume 2 370 517 -28.5 % 7,760 10,860 -28.5 % 390 -14.0 % 73,273 -14.5 % NYSE Group Matched Volume 3 295 443 -33.4 % 6,191 9,294 -33.4 % 318 -16.2 % 59,832 -16.6 % Total Nasdaq Listed Consolidated Volume 2,411 2,531 -4.8 % 50,627 53,157 -4.8 % 2,299 1.4 % 432,146 0.9 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 15.3 % 20.4 % -5.1 % 15.3 % 20.4 % -5.1 % 17.0 % -3.1 % 17.0 % -3.1 % Matched Volume 3 12.2 % 17.5 % -5.3 % 12.2 % 17.5 % -5.3 % 13.8 % -3.0 % 13.8 % -3.0 %   Exchange-Traded Funds 1,4   NYSE Group Handled Volume 2 364 708 -48.6 % 7,638 14,862 -48.6 % 556 26.9 % 104,496 26.3 % NYSE Group Matched Volume 3 317 623 -49.1 % 6,656 13,075 -49.1 % 487 27.2 % 91,621 26.6 % Total ETF Consolidated Volume 1,461 2,171 -32.7 % 30,679 45,600 -32.7 % 2,068 56.3 % 388,848 55.5 %   NYSE Group Share of Total Consolidated Volume Handled Volume 2 24.9 % 32.6 % -7.7 % 24.9 % 32.6 % -7.7 % 26.9 % -6.2 % 26.9 % -6.2 % Matched Volume 3 21.7 % 28.7 % -7.0 % 21.7 % 28.7 % -7.0 % 23.6 % -5.3 % 23.6 % -5.3 %

NYSE Euronext

Monthly Volume Summary - Derivatives Products

                    Average Daily Volume Total Volume   Average Daily Volume Total Volume (Unaudited; contracts in thousands) Sep-09 Sep-08 % Chg Sep-09 Sep-08 % Chg YTD 2009

% Chg vs. YTD 2008

YTD 2009

% Chg vs. YTD 2008

  Number of Trading Days - European Markets 22 22 22 22 191 191 Number of Trading Days - U.S. Markets 21 21 21 21 188 188   European Derivatives Products 4,355 4,800 -9.3 % 95,817 105,605 -9.3 % 4,147 -2.1 % 792,109 -2.6 % of which Bclear 842 995 -15.3 % 18,531 21,884 -15.3 % 1,071 41.6 % 204,565 40.9 %   Total Interest Rate Products 2,282 2,274 0.4 % 50,210 50,021 0.4 % 2,016 -12.8 % 385,125 -13.2 %   Short Term Interest Rate Products 2,182 2,165 0.8 % 48,006 47,631 0.8 % 1,917 -13.0 % 366,212 -13.5 % Medium and Long Term Interest Rate Products 5 100 109 -7.7 % 2,205 2,390 -7.7 % 99 -6.7 % 18,913 -7.2 %   Total Credit Derivatives Products (Bclear) - - - - - -   Total Equity Products 6 2,021 2,477 -18.4 % 44,462 54,483 -18.4 % 2,084 11.3 % 397,997 10.7 %   Individual Equity Products 1,350 1,614 -16.3 % 29,699 35,499 -16.3 % 1,467 20.1 % 280,130 19.5 % Equity Index Products 671 863 -22.2 % 14,762 18,984 -22.2 % 617 -5.2 % 117,867 -5.7 %   of which Bclear 842 995 -15.3 % 18,531 21,884 -15.3 % 1,071 41.6 % 204,565 40.9 % Individual Equity Products 687 858 -19.9 % 15,112 18,875 -19.9 % 939 44.4 % 179,381 43.6 % Equity Index Products 155 137 13.7 % 3,419 3,008 13.7 % 132 24.5 % 25,184 23.9 %   Commodity Products 52 50 4.0 % 1,145 1,101 4.0 % 47 -13.3 % 8,987 -13.7 %   U.S. Derivatives Products   Equity Options 7   NYSE Group Options Contracts 2,998 2,007 49.4 % 62,948 42,140 49.4 % 2,486 43.1 % 467,409 42.4 % Total Consolidated Options Contracts 13,993 16,252 -13.9 % 293,863 341,302 -13.9 % 13,530 1.4 % 2,543,548 0.9 %   NYSE Group Share of Total 21.4 % 12.3 % 21.4 % 12.3 % 18.4 % 5.4 % 18.4 % 5.4 %   NYSE Liffe U.S.   Futures and Futures Options Volume 20.6 - 431.8 - 16.6 - 3,113.5 - 1   Includes all volume executed in NYSE Group crossing sessions. 2 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 3 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 4 Data included in previously identified categories. 5 Data includes currency products.

6

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 7 Includes trading in U.S. equity options contracts, not equity-index options. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. US Equities data has been updated for Amex integration for October 2008 forward.